Let’s CLEAR things up: who benefits from low-dose colchicine?

European Journal of Preventive Cardiology

21 March 2025

Organised by:

Read full article

Contributors

Niekbachsh Mohammadnia

Niekbachsh Mohammadnia

Author

Cornelis Kramers

Cornelis Kramers

Author

Aysun Cetinyurek-Yavuz

Aysun Cetinyurek-Yavuz

Author

Saloua El Messaoudi

Saloua El Messaoudi

Author

University Medical Centre St Radboud (UMCN) Nijmegen , Netherlands (The)

You may be interested in

Congress Presentation

Low-dose colchicine in patients treated with percutaneous coronary interventions for myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

29 August 2020

ESC TV Today

Episode 10: Non-bacterial thrombotic endocarditis - Managing cardiovascular risk in transgender people

27 February 2025

Congress Session

Clonal hematopoiesis of indeterminate potential in cardiovascular disease: from atherosclerosis to heart failure

17 May 2025

Congress Presentation

Individual lifetime benefit from low-dose colchicine in chronic coronary artery disease patients

26 August 2022

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources